Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.
Alveolus Bio a pioneering respiratory drug development biotech company founded by Dr Vivek Lal from University of Alabama at Birmingham AL has announced a strategic financing round led by Shilpa Medicare Limited
Anbogen Therapeutics today announced that the US Food and Drug Administration FDA has approved its Investigational New Drug IND application for ABT enabling the initiation of a Phase clinical trial i
SyVento BioTech is proud to announce that as of July the company has officially obtained the ManufacturerImporter Authorisation MIA a vital regulatory certification that enables the manufacturing and importation
Harrowa leading North American eyecare pharmaceutical company today announced that it has entered into a definitive agreement with Samsung Bioepis Co Ltd hereafter Samsung Bioepis to secure the exclusive
Hansa Biopharma AB Hansa today announced topline results from three patients with Duchenne muscular dystrophy DMD treated with Hansas imlifidase prior to receiving Sareptas ELEVIDYS delandistrogene moxeparvovecrokl in the SRP trial
Arrowhead Pharmaceuticals Inctoday announced the signing of an asset purchase agreement between Sanofi and Visirna Therapeutics a majorityowned subsidiary of Arrowhead created to develop and commercialize
Charles River Laboratories International Inc and BioTech Social Inc BSI today announced the exploration of a potential clientcentric collaboration to enable Charles River Incubator CIP and Accelerator
Supernus Pharmaceuticals Inctoday announced that it has successfully completed its previously announced acquisition of Sage Therapeutics Inc Nasdaq SAGE Sage
Azenta Inc Nasdaq AZTA today announced that it has entered a collaboration with Frenova a division of Fresenius Medical Care and Nephronomics a Renal Precision Medicine company to begin genomic
Novartis announced today that the US Food and Drug Administration FDA has approved a label update for Leqvio inclisiran enabling its use as monotherapy along with diet and exercise to reduce lowdensity lipoprotein cholesterol
